Abstract
This study examined the expression of human growth hormone-releasing hormone receptor (GHRH-R) mRNA in both non-neoplastic pituitary tissues and pituitary adenomas by reverse transcriptase-polymerase chain reaction (RT-PCR) and in situ hybridization (ISH).
RT-PCR analysis showed that all of the non-neoplastic pituitaries and all GH-producing adenomas, one prolactinoma and one third of the non-functioning adenomas expressed GHRH-R mRNA. ISH demonstrated that all of GH-producing adenomas and two prolactinomas expressed GHRH-R mRNA. The expression of GHRH-R mRNA in GH-producing adenomas was greater than that in the other adenomas by RT-PCR and ISH. GHRH-R mRNA detected by ISH was observed only in GH cells from the pituitary gland of a young girl. In pituitary adenomas, a diffuse signal was observed in the cytoplasm of all of the GH-producing adenomas and in two prolactinomas. Expression of GHRH-R mRNA was not seen in normal prolactin cells, or in any adenomas other than GH-producing adenomas and a few prolactinomas.
These results suggest that GHRH-R mRNA plays a role mainly in the function of GH-producing adenomas but may also play a role in function of some prolactinomas.
Similar content being viewed by others
References
Billesrup N, Swanson LW, Vale W: Growth hormonereleasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA1986; 83: 6845–6857.
Frohman L, Jansson JO: Growth hormone-releasing hormone. Endocr Rev 1986; 7: 223–253.
Gaylinn BD, Harrison JK, Zysk JR, Lyons CE, Lynch KR, Thorner MO: Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. Mol Endocrinol 1993; 7: 77–84.
Mayo KE: Molecular cloning and expression of a pituitaryspecific receptor for growth hormone-releasing hormone. Mol Endocrinol 1992; 6: 1734–1744.
Hashimoto K, Koga M, Motomura T, Kasayama S, Kouhara H, Ohnishi T, Arita N, Hayakawa T, Sato B, Kishimoto T: Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas. J Clin Endocrinol Metab 1995, 80: 2933–2939.
Lopes MBS, Gaylinn BD, Thorner MO, Stoler MH: Growth hormone-releasing hormone receptor mRNA in Acromegalic pituitary tumors. Am J Pathol 1997; 150: 1885–1891.
Gussow D, Rein R, Ginjaar I, Hochstenbach F, Seemaun G, Kottman A, Ploegh HL: The human_2–microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol 1987; 139: 3132–3138.
Sassolas G, Chatelain P, Cohen R, Boissel JP, Laporte S, Galleyrand J, Claustrat B, Elmcharfi A, Chayvialle JA, Cohen H, Ferry S, Underwood L: Effects of human pancreatic tumor growth hormone-releasing hormone (hpGRH1–44–NH2) on immunoreactive and bioactive plasma growth hormone in normal young men. J Clin Endocrinol Metab 1984; 59: 705–709.
Wada C, Kasai K, Kameya T, Ohtani H: A general transcription initiation factor, human transcription factor IID, overexpressed in human lung and breast carcinoma and rapidly induced with serum stimulation. Cancer Res 1992; 52: 307–313.
Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463–5467.
Hirota S, Ito A, Morii E, Wanaka A, Tohyama M, Kitamura Y, Nomura S: Localization of mRNA for c-kit receptor and its ligand in the brain of adult rat: an analysis using in situ hybridization. Mol Brain Res 1992; 15: 47–54.
Seifert H, Perrin M, Rivier J, Vale W: Binding sites for growth hormone releasing factor on rat anterior pituitary cell. Nature 1985; 313: 487–489.
Seifert H, Perrin M, Rivier J, Vale W: Growth hormonereleasing factor binding sites in rat anterior pituitary membrane homogenates: modulation by glucocorticoids. Endocrinology 1985; 117: 424–426.
Velicelebi G, Patthi S, Provow S, Akong M: Covalent crosslinking of growth hormone-releasing factor to pituitary receptors. Endocrinology 1986; 118: 1278–1283.
Velicelebi G, Santacrose TM, Harpold MM: Specific binding of synthetic human pancreatic growth hormone releasing factor (1–40)OHto bovine anterior pituitaries. Biochem Biophys Res Commun 1985; 126: 33–39.
Morel G: Uptake and ultrastructural localization of a [125I] growth hormone releasing factor agonist in male rat pituitary gland: evidence for internalization. Endocrinology 1991; 129: 1497–1504.
Lin C, Lin SC, Chang CP, Rosenfeld MG: Pt-1–dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 1992; 360: 765–768.
Melmed S: Etiology of pituitary acromegaly, Endoclinol Metab Clin North Am 1992; 21: 539–551.
Penny ES, Penman E, Price J, Rees LH, Sopwith AM, Wass JAH, Besser GM: Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. Br Med J (Clin Res) 1984; 289: 453–455.
Thorner MO, Frohman LA, Leong DA, Thominet J, Downs T, Hellmann P, Chitwood J, Vaughan JM, Vale W: Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J Clin Endocrinol Metab 1984; 59: 846–849.
Argente J, Evain-Brion D, Munoz-Villa A, Gamier P, Hernandez M, Donnadieu M: Relationship of plasma growth hormone-releasing hormone levels to pubertal changes. JClin Endocrinol Metab 1986; 63: 680–682.
Goldman JA, Molitch ME, Thorner MO, Vale TW, Rivier J, Reichlin S: Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1–40–OH in man. J Endocrinol Invest1987; 10: 397–406.
Evans WS, Borges JLC, Vance ML, Kaiser DL, Rogol AD, Furlanetto R, Rivier J, Vale W, Thorner MO: Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle. J Clin Endocrinol Metab 1984; 59: 1006–1010.
Losa M, Schopohl J, Muller A, vonWerer K: Growth hormone releasing factor induces prolactin secretion in acromegalic patients but not in normal subjects. Acta Endocrinol (Kbh.) 1995; 109: 467–473.
Rosenthal SM, Schriock EA, Kaplan SL, Guillemin R, Grumbach MM: Synthetic human pancreas growth hormonereleasing factor (hpGRF1–44–NH2) stimulates growth hormone secretion in normal men. JClin Endocrinol Metab 1983; 57: 677–679.
Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K:Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormonereleasing factor. J Clin Invest 1982; 70: 965–977.
Thorner MO, Rivier J, Spiess J, Borges JL, Vance ML, Bloom SR, Regol AD, Cronin MJ, Kaiser DL, Evans WS, Webster JD, MacLeod RM, Vale W: Human pancreatic growthhormone-releasing factor selectively stimulates growthhormone secretion in man. Lancet 1983; 1: 24.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oka, H., Kameya, T., Sato, Y. et al. Significance of Growth Hormone-releasing Hormone Receptor mRNA in Non-neoplastic Pituitary and Pituitary Adenomas: A Study by RT-PCR and in situ Hybridization. J Neurooncol 41, 197–204 (1999). https://doi.org/10.1023/A:1006151001536
Issue Date:
DOI: https://doi.org/10.1023/A:1006151001536